Skip to main content

CM Management, LLC

SEC CIK
0001841857
Latest filing
Aug 13, 2026

RIGL holding history

Rigel Pharmaceuticals Inc in every 13F filed by CM Management, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RIGL overviewAll 13F holders of RIGLFull Q2 2026 holdings

Shares (Q2 2026)
250,000
Value
$9.78M
% of portfolio
6.2%
Quarters held
21
Since Q1 2021
Holdings of RIGL by CM Management, LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026250,000$9.78M6.2%+15,000+6.4%AddedHolders
Q1 2026235,000$6.35M5.3%+10,000+4.4%AddedHolders
Q4 2025225,000$9.64M8.1%00.0%UnchangedHolders
Q3 2025225,000$6.37M5.3%−25,000−10.0%ReducedHolders
Q2 2025250,000$4.68M4.3%00.0%UnchangedHolders
Q1 2025250,000$4.50M4.5%+7,500+3.1%AddedHolders
Q4 2024242,500$4.08M3.6%−47,500−16.4%ReducedHolders
Q3 2024290,000$4.69M3.7%+290,000NewHolders
Q2 20240$00.0%−200,000−100.0%Sold outConverted for a 1-for-10 splitHolders
Q1 20242,000,000$2.96M2.5%+300,000+17.6%AddedHolders
Q4 20231,700,000$2.46M2.0%+200,000+13.3%AddedHolders
Q3 20231,500,000$1.62M1.7%00.0%UnchangedHolders
Q2 20231,500,000$1.94M1.9%00.0%UnchangedHolders
Q1 20231,500,000$1.98M2.4%00.0%UnchangedHolders
Q4 20221,500,000$2.25M2.7%+200,000+15.4%AddedHolders
Q3 20221,300,000$1.53M1.7%00.0%UnchangedHolders
Q2 20221,300,000$1.47M1.6%+525,000+67.7%AddedHolders
Q1 2022775,000$2.32M1.9%00.0%UnchangedHolders
Q4 2021775,000$2.05M1.6%+25,000+3.3%AddedHolders
Q3 2021750,000$2.72M2.0%00.0%UnchangedHolders
Q2 2021750,000$3.25M2.4%+250,000+50.0%AddedHolders
Q1 2021500,000$1.71M1.3%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.